rosiglitazone has been researched along with Exophthalmos in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clevidence, DE; Juckett, MB; Lucarelli, MJ | 1 |
Kazim, M; Levin, F; Marcovici, E; Smith, TJ | 1 |
Goldberg, RA; Lee, S; McCann, JD; Tsirbas, A | 1 |
3 other study(ies) available for rosiglitazone and Exophthalmos
Article | Year |
---|---|
Marrow suppression with myelodysplastic features, hypoerythropoetinemia, and lipotrophic proptosis due to rosiglitazone.
Topics: Diabetes Mellitus, Type 2; Erythropoietin; Exophthalmos; Female; Humans; Hypoglycemic Agents; Lipodystrophy; Middle Aged; Myelodysplastic Syndromes; Rosiglitazone; Thiazolidinediones | 2009 |
Rosiglitazone-induced proptosis.
Topics: Diabetes Mellitus, Type 2; Exophthalmos; Eye; Female; Humans; Hypoglycemic Agents; Middle Aged; Rosiglitazone; Thiazolidinediones; Thyroid Function Tests; Tomography, X-Ray Computed; Weight Gain | 2005 |
Thiazolidinedione induced thyroid associated orbitopathy.
Topics: Diplopia; Disease Progression; Drug Therapy, Combination; Exophthalmos; Female; Graves Ophthalmopathy; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Metformin; Middle Aged; Propranolol; Propylthiouracil; Retreatment; Rosiglitazone; Thiazolidinediones | 2007 |